AusPAR: Aflibercept

Australian Public Assessment Report

AusPAR

Australian Public Assessment Report for Aflibercept [PDF, 1.68 MB]

Australian Public Assessment Report for Aflibercept [Word, 2.04 MB]

AusPAR Attachment 1: Product information for Aflibercept [PDF, 757.08 KB]

AusPAR Attachment 1: Product information for Aflibercept [Word, 775.64 KB]

AusPAR Attachment 2: Extract from the Clinical Evaluation Report for Aflibercept [PDF, 2.86 MB]

AusPAR Attachment 2: Extract from the Clinical Evaluation Report for Aflibercept [Word, 3.29 MB]

Device/Product Name

Eylea

Active ingredients

Aflibercept

AusPAR Date

21 July 2015

Published

6 August 2015

Submission Number

PM-2013-04198-1-1

Submission Type

Extension of indications

Decision

Approved